SCHEMBL584092

SCHEMBL584092

CCC(CCC(C)C)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.60
MAPK1 P28482 1/20 0.60
SLC1A3 P43003 5/20 0.57
SLC1A2 P43004 5/20 0.57
SLC1A1 P43005 4/20 0.57
CHRM1 P11229 1/20 0.50
AKR1A1 P14550 1/20 0.50
CHRM3 P20309 1/20 0.50
HTR2A P28223 1/20 0.50
HTR2C P28335 1/20 0.50
ADRA1A P35348 1/20 0.50
HRH1 P35367 1/20 0.50
DRD3 P35462 1/20 0.50
SLC6A3 Q01959 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC2 Q92769 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
GCLC P48506 2/20 0.41
BLM P54132 1/20 0.40
GRIK1 P39086 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18307368 1.00 CA2 (0.60) CA2MAPK1SLC1A3SLC1A2SLC1A1
SCHEMBL125406 0.89 CA2 (0.71) CA2MAPK1SLC1A3SLC1A2SLC1A1
SCHEMBL9115232 0.87 SLC1A3 (0.64) CA2MAPK1SLC1A3SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL11070878 0.87 CA2 (0.83) CA2MAPK1SLC1A3SLC1A2SLC1A1
SCHEMBL2893016 0.86 CA2 (0.68) CA2MAPK1SLC1A3SLC1A2SLC1A1
SCHEMBL1509190 0.86 CA2 (0.68) CA2MAPK1SLC1A3SLC1A2SLC1A1
SCHEMBL6617648 0.85 CA2 (0.60) CA2MAPK1SLC1A3SLC1A2SLC1A1
SCHEMBL6363268 0.84 CA2 (0.65) CA2MAPK1SLC1A3SLC1A2SLC1A1
SCHEMBL10816802 0.84 CA2 (0.65) CA2MAPK1SLC1A3SLC1A2SLC1A1
SCHEMBL8028607 0.84 CA2 (0.65) CA2MAPK1SLC1A3SLC1A2SLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 679 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4302747-B1 SYSTEM FOR DISPENSING A COSMETIC PRODUCT OREAL (FR) 2026-01-14 EP claimed
US-20250352444-A1 Antimicrobial mixtures SYMRISE AG (DE) 2025-11-20 US claimed
EP-3648613-B1 COMPOSITIONS AND METHODS FOR A UNIVERSAL CLINICAL TEST FOR OLFACTORY DYSFUNCTION UNIV ROCKEFELLER (US) 2025-09-24 EP claimed
EP-4444108-B1 ALDEHYDE MIXTURES FOR FLAVOUR IMPROVEMENT SYMRISE AG (DE) 2025-09-10 EP claimed
EP-4525822-A1 ANTIMICROBIAL MIXTURES Symrise AG (DE) 2025-03-26 EP claimed
EP-4255208-B1 CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS VOYAGE FOODS INC (US) 2024-12-25 EP claimed
EP-4245832-B1 DETERGENT COMPOSITIONS PROCTER & GAMBLE (US) 2024-11-20 EP claimed
EP-3930472-B1 COFFEE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS VOYAGE FOODS INC (US) 2024-09-11 EP claimed
EP-4161293-B1 FLAVOURING COMPOSITION WITH BALANCED TASTE PROFILE SYMRISE AG (DE) 2024-01-31 EP claimed
EP-4302747-A1 SYSTEM FOR DISPENSING A COSMETIC PRODUCT L'OREAL (FR) 2024-01-10 EP claimed
EP-2158896-A2 Materials containing aromas incorporating neopentyl glycol isononanoate Symrise GmbH & Co. KG (DE) 2010-03-03 EP claimed
EP-2134377-A1 FRAGRANCE DISPENSER Symrise GmbH & Co. KG (DE) 2009-12-23 EP claimed
WO-2008104226-A1 FRAGRANCE DISPENSER SYMRISE GMBH & CO. KG (DE) 2008-09-04 WO claimed
EP-1469037-B1 SOLVENT-SOLUBLE BLOCK COPOLYIMIDE COMPOSITION AND PROCESS FOR PRODUCING THE SAME PI R & D CO LTD (JP) 2008-08-06 EP claimed
EP-1697386-B1 ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES GEN ELECTRIC (US) 2007-10-10 EP claimed
US-6844302-B1 Encapsulated flavor and fragrance INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2005-01-18 US claimed
EP-1135363-B1 PROCESS FOR THE PREPARATION OF SYMMETRICAL DIACYLHYDRAZINES GREAT LAKES CHEMICAL EUROP (CH) 2003-09-24 EP claimed
EP-0976726-B1 Dimethylsulphide composition with masked odour ATOFINA (FR) 2003-05-28 EP claimed
EP-0566794-B1 Serum and plasma separating compositions and blood testing containers SEKISUI CHEMICAL CO LTD (JP) 1997-08-27 EP claimed
US-4250200-A Flavoring with a mixture of isochroman musk compounds INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1981-02-10 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250352444-A1 Antimicrobial mixtures LRBA, MGLL, TAS2R50 CA2 3362/4885MAPK1 4274/4885SLC1A3 4849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.